CAPDM Welcomes Tolmar Pharmaceuticals Canada, Inc.

Tolmar, the global developer and worldwide manufacturer of ELIGARD®, is establishing commercial operations in Canada and now has dedicated local teams with expertise in uro-oncology to support ELIGARD® in meeting the needs of Canadian healthcare providers and patients.
 
Tolmar is a fully integrated specialty pharmaceutical company with a strong track record of successful commercialization of ELIGARD® either through licensing partnerships or through Tolmar-owned commercialization capabilities across 89 countries around the world.

For more information please visit: www.tolmar.ca